Nanoscale crystallographic characterization of nanoporous catalyst by TKD
Sign Up to like & getrecommendations! Published in 2019 at "Applied Surface Science"
DOI: 10.1016/j.apsusc.2019.05.187
Abstract: Abstract To better understand the structure-reactivity relationships of self-supported nanoporous catalysts, a nanoscale characterization of the materials is required. Transmission Kikuchi Diffraction (TKD), or transmission electron backscatter diffraction (t-EBSD), is a recent technique used to… read more here.
Keywords: characterization nanoporous; characterization; nanoporous catalyst; nanoscale crystallographic ... See more keywords
SEM and TEM characterization of plastic deformation structures in Aluminum by EBSD, TKD, and PED-based orientation imaging techniques
Sign Up to like & getrecommendations! Published in 2018 at "Microscopy and Microanalysis"
DOI: 10.1017/s143192761801139x
Abstract: Diffraction-based analytical techniques for orientation imaging microscopy (OIM) with scanning and transmission electron microscope (SEM and TEM) instruments, such as electron backscatter diffraction (EBSD), transmission Kikuchi diffraction (TKD), and precession electron diffraction-assisted automated crystal orientation… read more here.
Keywords: deformation structures; orientation; microscopy; tkd ... See more keywords
Exploring binding stability of hydroxy-3-(4-hydroxyphenyl)-5-(4-nitrophenyl)-5,5a,7,8,9,9a-hexahydrothiazolo[2,3-b] quinazolin-6-one with T790M/L858R EGFR-TKD
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biomolecular Structure and Dynamics"
DOI: 10.1080/07391102.2022.2053748
Abstract: Abstract Cancer causes innumerable deaths every year globally. Breast cancer and non-small cell lung carcinoma are the most prevalent worldwide. EGFR-TKD is a neoplastic survival therapeutic target in a wide array of carcinoma cells. Various… read more here.
Keywords: tkd; hydroxyphenyl nitrophenyl; egfr tkd; hydroxy hydroxyphenyl ... See more keywords
Abstract 7220: Zongertinib demonstrates potent efficacy against cancer cells harboring HER2 non-tyrosine kinase domain mutations
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-7220
Abstract: Activating mutations in HER2 are found in approximately 2-4% of non-small cell lung cancer (NSCLC). Recurrent activating mutations most commonly occur in the tyrosine kinase domain (TKD) encoded by exons 18-21, with exon 20 insertions… read more here.
Keywords: tkd mutations; cancer; tkd; her2 ... See more keywords
Comprehensive characterization of ERBB2 genomic alterations inlung cancer.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.3148
Abstract: 3148 Background: ERBB2mutations () occur in 1-4% of non-small cell lung cancers (NSCLC). Trastuzumab-deruxtecan is FDA-approved for the treatment of metastatic ERBB2-mutant NSCLC based mostly on data from NSCLCs harboring tyrosine kinase domain (TKD) ERBB2mut.… read more here.
Keywords: ecd; erbb2; mut; erbb2 mutant ... See more keywords
Temporary kidney dysfunction (TKD): supplementation with Meriva® in initial, transient kidney micro-macro albuminuria.
Sign Up to like & getrecommendations! Published in 2018 at "Panminerva medica"
DOI: 10.23736/s0031-0808.18.03575-9
Abstract: BACKGROUND The aim of this registry was to evaluate the efficacy of Meriva® in subjects with temporary kidney dysfunction (TKD) and increased oxidative stress levels. TKD was a casual finding on urinary tests after reported… read more here.
Keywords: kidney dysfunction; tkd; dysfunction tkd; temporary kidney ... See more keywords